Primary |
Depression |
50.0% |
Dementia |
25.0% |
Low Density Lipoprotein Increased |
16.7% |
Chronic Myeloid Leukaemia |
8.3% |
|
Delirium |
50.0% |
Drug Interaction |
25.0% |
Suicide Attempt |
25.0% |
|
Secondary |
Depression |
17.6% |
Insomnia |
16.9% |
Drug Use For Unknown Indication |
12.0% |
Anxiety |
8.3% |
Feeling Abnormal |
7.6% |
Frustration |
7.6% |
Self Injurious Behaviour |
7.6% |
Schizophrenia |
3.6% |
Product Used For Unknown Indication |
3.5% |
Hypertension |
2.9% |
Suicide Attempt |
2.0% |
Constipation |
1.5% |
Parkinson's Disease |
1.3% |
Sleep Disorder |
1.3% |
Essential Hypertension |
1.1% |
Insomnia Related To Another Mental Condition |
1.1% |
Intentional Overdose |
1.1% |
Thrombosis Prophylaxis |
1.1% |
Hallucination |
1.0% |
Bipolar Ii Disorder |
0.9% |
|
Somnolence |
8.4% |
Constipation |
7.2% |
Hyperphagia |
7.2% |
Overdose |
7.2% |
Swollen Tongue |
7.2% |
Suicide Attempt |
6.0% |
Abnormal Behaviour |
4.8% |
Brugada Syndrome |
4.8% |
Eosinophilia |
4.8% |
Fall |
4.8% |
Insomnia |
4.8% |
Blepharospasm |
3.6% |
Multiple Drug Overdose |
3.6% |
Neuroleptic Malignant Syndrome |
3.6% |
Respiratory Failure |
3.6% |
Sepsis |
3.6% |
Suicidal Ideation |
3.6% |
Syncope |
3.6% |
Tremor |
3.6% |
Ventricular Arrhythmia |
3.6% |
|
Concomitant |
Product Used For Unknown Indication |
19.3% |
Prophylaxis |
12.1% |
Insomnia |
10.8% |
Rheumatoid Arthritis |
8.4% |
Drug Use For Unknown Indication |
7.4% |
Hypertension |
6.6% |
Hiv Infection |
5.3% |
Depression |
4.2% |
Constipation |
3.6% |
Schizophrenia |
3.2% |
Multiple Myeloma |
2.6% |
Gastritis Prophylaxis |
2.3% |
Infection Prophylaxis |
2.2% |
Crohn's Disease |
1.9% |
Diabetes Mellitus |
1.8% |
Aplastic Anaemia |
1.8% |
Gastritis |
1.8% |
Adverse Event |
1.7% |
Pain |
1.6% |
Psoriasis |
1.4% |
|
Vomiting |
9.6% |
Pneumonia |
8.2% |
White Blood Cell Count Decreased |
8.2% |
Interstitial Lung Disease |
6.9% |
Rhabdomyolysis |
5.5% |
Tachycardia |
5.2% |
Pyrexia |
4.9% |
Sepsis |
4.9% |
Liver Disorder |
4.7% |
White Blood Cell Count Increased |
4.7% |
Rash |
4.4% |
Intestinal Obstruction |
4.1% |
Weight Increased |
4.1% |
Somnolence |
3.8% |
Water Intoxication |
3.8% |
Cerebral Haemorrhage |
3.6% |
Platelet Count Decreased |
3.3% |
Restlessness |
3.3% |
Schizophrenia |
3.3% |
Shock |
3.3% |
|
Interacting |
Drug Use For Unknown Indication |
50.0% |
Nail Tinea |
50.0% |
|
|